European Union · Record · QUESTION_WRITTEN_PRIORITY
P-10-2025-000048
Market approval for an RNA-based vaccine with self-amplifying mRNA
Introduced
8 January 2025
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 February 2025
Records
Official record P-10-2025-000048 from European Union at European Parliament. Dated 8 January 2025. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Marketing authorisation for an RNA-based vaccine with self-strengthening mRNA
This file cannot be previewed here. Use View or Download.
Marketing authorisation for an RNA-based vaccine with self-strengthening mRNA
QUESTION_WRITTEN_PRIORITY · EN · 13 January 2025
Marketing authorisation for an RNA-based vaccine with self-strengthening mRNA
QUESTION_WRITTEN_PRIORITY · EN · 13 January 2025
Answer
QUESTION_WRITTEN_ANSWER · 20 February 2025
Marktzulassung für einen RNA-basierten Impfstoff mit selbstverstärkender mRNA
QUESTION_WRITTEN_PRIORITY · DE · 13 January 2025
Marktzulassung für einen RNA-basierten Impfstoff mit selbstverstärkender mRNA
QUESTION_WRITTEN_PRIORITY · DE · 13 January 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.